Anixa Biosciences, Inc. (ANIX) vs Coya Therapeutics, Inc. (COYA)

A side-by-side comparison of Anixa Biosciences, Inc. and Coya Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANIX vs COYA

growth of $100 · dividends reinvested · last 4y
ANIX -24.9% (-6.9%/yr)COYA +6.1% (+1.5%/yr)COYA compounded faster over this window
50100150200Start $1002023202420252026$75$106
ANIX COYA

ANIX vs COYA: by the numbers

  • •COYA is the larger company ($118M vs $105M market cap).
  • •Both run net losses; ANIX's is the smaller (0.00% vs -270.22% net margin).

Metrics side by side

Valuation

MetricANIXCOYA
P/S ratioN/A14.68
P/B ratio7.250.00

Profitability

MetricANIXCOYA
Gross margin0.00%99.91%
Operating margin0.00%-255.05%
Net margin0.00%-270.22%
ROE-72.02%-0.05%
ROIC-82.35%-0.05%

Growth (annualized)

MetricANIXCOYA
Total return CAGR (5Y)-8.26%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.